These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11926798)

  • 1. Acute exacerbations of chronic obstructive pulmonary disease.
    Stey C
    Ann Intern Med; 2002 Apr; 136(7):556-8; author reply 556-8. PubMed ID: 11926798
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acetylcysteine in chronic obstructive pulmonary disease. Secretolytic, antioxidant or placebo?].
    Randerath W; Galetke W
    Med Monatsschr Pharm; 2003 Nov; 26(11):375-8. PubMed ID: 14652922
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cell oxidative processes and antioxidant mucoactive drugs].
    González-Mangado N; Morera Prat J
    Arch Bronconeumol; 2001 Nov; 37(10):407-10. PubMed ID: 11734120
    [No Abstract]   [Full Text] [Related]  

  • 4. N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease.
    Gerrits CM; Herings RM; Leufkens HG; Lammers JW
    Eur Respir J; 2003 May; 21(5):795-8. PubMed ID: 12765423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
    Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
    COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
    Sadowska AM
    Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation pathway and exacerbations in COPD: the role of NAC.
    Matera MG; Calzetta L; Cazzola M
    Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of N-acetylcysteine in the treatment of chronic obstructive pulmonary disease.
    van Herwaarden CL; Bast A; Dekhuijzen PN
    Neth J Med; 1995 Aug; 47(2):45-8. PubMed ID: 7566280
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medical maintenance treatment of chronic obstructive pulmonary disease (COPD)].
    Kerstjens HA; Postma DS
    Ned Tijdschr Geneeskd; 2002 Aug; 146(35):1631-5. PubMed ID: 12233157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbocisteine for acute exacerbations of COPD.
    Waller P; Suissa S
    Lancet; 2008 Nov; 372(9650):1630; author reply 1631-2. PubMed ID: 18994655
    [No Abstract]   [Full Text] [Related]  

  • 11. Erdosteine for COPD exacerbations.
    Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine in patients with COPD exacerbations associated with increased sputum.
    Ayfer Aytemur Z; Baysak A; Ozdemir O; Köse T; Sayiner A
    Wien Klin Wochenschr; 2015 Apr; 127(7-8):256-61. PubMed ID: 25595117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbocisteine for acute exacerbations of COPD.
    Mohapatra PR; Aggarwal D
    Lancet; 2008 Nov; 372(9650):1630-1; author reply 1631-2. PubMed ID: 18994656
    [No Abstract]   [Full Text] [Related]  

  • 14. 2014 American Thoracic Society International Conference.
    Kang S
    Lancet Respir Med; 2014 Jul; 2(7):518-20. PubMed ID: 25140364
    [No Abstract]   [Full Text] [Related]  

  • 15. A PEACE-ful solution to COPD exacerbations?
    Albert P; Calverley P
    Lancet; 2008 Jun; 371(9629):1975-6. PubMed ID: 18555897
    [No Abstract]   [Full Text] [Related]  

  • 16. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
    Calzetta L; Matera MG; Rogliani P; Cazzola M
    Expert Rev Respir Med; 2018 Aug; 12(8):693-708. PubMed ID: 29972340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine is unlikely to reduce hospitalisation for chronic obstructive pulmonary disease.
    Ernst P; Suissa S
    Eur Respir J; 2003 Nov; 22(5):865; author reply 865-6. PubMed ID: 14621098
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis.
    Schermer T; Chavannes N; Dekhuijzen R; Wouters E; Muris J; Akkermans R; van Schayck O; van Weel C
    Respir Med; 2009 Apr; 103(4):542-51. PubMed ID: 19138505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treating acute exacerbations of chronic bronchitis with N-acetylcysteine?].
    Behr J
    Pneumologie; 2002 Dec; 56(12):768-9. PubMed ID: 12486613
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections.
    Blasi F; Page C; Rossolini GM; Pallecchi L; Matera MG; Rogliani P; Cazzola M
    Respir Med; 2016 Aug; 117():190-7. PubMed ID: 27492531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.